JP MORGAN/PUT/ABBOTT LABORATORIES/85/0.1/17.01.25 Stock

Warrant

DE000JL03G64

Market Closed - Börse Stuttgart 03:01:27 2024-06-28 EDT
0.1 EUR +2.04% Intraday chart for JP MORGAN/PUT/ABBOTT LABORATORIES/85/0.1/17.01.25
Current month-28.57%
1 month-9.09%
Date Price Change
24-06-28 0.1 +2.04%
24-06-27 0.098 -1.01%
24-06-26 0.099 +4.21%
24-06-25 0.095 -5.00%
24-06-24 0.1 +4.17%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 03:01 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JL03G6
ISINDE000JL03G64
Date issued 2023-04-05
Strike 85 $
Maturity 2025-01-17 (201 Days)
Parity 10 : 1
Emission price 0.55
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.79
Lowest since issue 0.083
Delta-0.12x
Omega 9.463
Premium19.41x
Gearing80.83x
Moneyness 0.8183
Difference Strike -18.91 $
Difference Strike %-22.25%
Spread 0.02
Spread %15.38%
Theoretical value 0.1200
Implied Volatility 26.43 %
Total Loss Probability 84.02 %
Intrinsic value 0.000000
Present value 0.1200
Break even 83.71 €
Theta-0.01x
Vega0.01x
Rho-0.01x

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.9 USD
Average target price
125.2 USD
Spread / Average Target
+20.45%
Consensus